Lactobacillus brevis BHN-LAB 127 having acetylcholinesterase inhibitory activity

摘要

The present invention provides a Lactobacillus brevis BHN-LAB 127 strain (Accession No: KCTC13441BP) having an acetylcholinesterase inhibitory activity and a composition comprising the same. Lactobacillus brevis BHN-LAB 127 strain of the present invention significantly inhibits acetylcholinesterase activity and is useful as a material for a pharmaceutical composition for treating Alzheimer's disease or a food composition for improving Alzheimer's symptoms, useful in the food processing, health functional food and pharmaceutical industries Can be.